Seqirus (or equal) seasonal influenza vaccine doses to FDA Occupational Health Units (OHUs) at the White Oak Campus in Silver Spring, MD, and the Jefferson Laboratories Campus in Jefferson, AR

Closed Solicitation Posted Jul 31, 2025

Solicitation number: 75F40125Q130864
Agency: FDA Office of Acquisition and Grant Services Food and Drug Administration, Department of Health and Human Services
Responses due: Aug 7, 2025, 3:00 PM ET
Set-aside: No set-aside

Opportunity facts

NAICS code: 325412 Pharmaceutical Preparation Manufacturing
PSC: 6505 Drugs And Biologicals
Points of contact: Suzanne Martella suzanne.martella@fda.hhs.gov (301) 796-2383

Notice details come from SAM.gov. Updated Aug 5, 2025.

About this opportunity

Written by GovTribe AI · Aug 5, 2025

The Food and Drug Administration (FDA) is seeking to procure 4,100 doses of seasonal influenza vaccines through a Request for Quote (RFQ) for delivery to their Occupational Health Units at two campus locations. The solicitation specifically requires 4,000 doses of Flucelvax TIV 0.5 mL prefilled syringes (or equivalent) for adults under 65 years of age and 100 doses of FLUAD TIV 0.5 mL prefilled syringes (or equivalent) for adults 65 years and older. All vaccines must be FDA-approved for the 2025-2026 influenza season, provided in single-dose pre-filled syringes, and shipped in compliance with CDC cold chain requirements. The contract will be awarded as a commercial product firm fixed price agreement using Simplified Acquisition Procedures. Quotes are due by August 7, 2025, at 2:00 PM Central Time and must be submitted via email to the Contracting Officer.

This solicitation operates under full and open competition with no set-aside designation, making businesses of any size eligible to participate under NAICS code 325412 (Pharmaceutical Preparation Manufacturing). The contract does not identify any incumbent contractors or specific budget ranges in the available documentation. The delivery requirements specify that 3,900 doses must be delivered to the White Oak Campus in Silver Spring, Maryland (comprising 3,800 doses for adults under 65 and 100 doses for adults 65 and older), while 200 doses for adults under 65 must be delivered to the Jefferson Laboratories Campus in Jefferson, Arkansas. All vaccines must be delivered by September 30, 2025, though delivery can occur anytime after contract award. The procurement reflects the FDA's internal occupational health program requirements for the upcoming flu season across these two key operational facilities.

Notice text

3 versions

Update #3 · Latest · Aug 5, 2025

UPDATE 08/05/2025: This update is to post another question and response thereto, and to post an amendment addressing all changes resulting from those questions. See attached Amendment A00001. The closing date for this RFQ is not changed.

Question #4: "Does the FDA require delivery of the vaccines all at once or as the product becomes available with final delivery by 09/30/2025?"

Response: Vaccines are required to be delivered anytime after contract award; however, all vaccines (100%) must arrive to the destination locations no later than by September 30, 2025.

UPDATE 08/01/2025: This posting is updated to reflect a quote due date of August 7, 2025, NOT August 5th, 2025.

This update is also to post Q&As that have been received, along with the Government's responses:

Question #1: "Is the volume requested in units or doses? Noting, each unit of influenza vaccine across all manufacturers represent 10 doses"

Response: "We are seeking doses of Flucelvax and 1,00 doses of FLUAD (or equal)."

Question #2: "Under the Requirement and Background on page 2, it states that the product should be FLUAD and Flucelvax. Is the requirement only to be a single-dose pre-filled syringe formulated for adults 65 years of age and older (similar to FLUAD) and a single-dose pre-filled syringe formulated for adults under 65 years of age (similar to Flucelvax)? Is the US FDA seeking an egg-free presentation."

Response: "We are seeking pre-filled syringes however, not specifically seeking an egg-free presentation."

Question #3: "Is the due date for responses August 5th or August 7th? Solicitation indicates the 7th but SAM says the 5th."

Response: "Quotes are due the 7th of August, as per the solicitation. SAM has been updated to reflect that, too."

ORIGINAL: See attached Solicitation/Request for Quote (RFQ) for Flu Vaccines for the Food and Drug Administration.

Update #2 · Aug 1, 2025